It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
When somatic cells acquire complex karyotypes, they often are removed by the immune system. Mutant somatic cells that evade immune surveillance can lead to cancer. Neurons with complex karyotypes arise during neurotypical brain development, but neurons are almost never the origin of brain cancers. Instead, somatic mutations in neurons can bring about neurodevelopmental disorders, and contribute to the polygenic landscape of neuropsychiatric and neurodegenerative disease. A subset of human neurons harbors idiosyncratic copy number variants (CNVs, “CNV neurons”), but previous analyses of CNV neurons are limited by relatively small sample sizes. Here, we develop an allele-based validation approach, SCOVAL, to corroborate or reject read-depth based CNV calls in single human neurons. We apply this approach to 2,125 frontal cortical neurons from a neurotypical human brain. SCOVAL identifies 226 CNV neurons, which include a subclass of 65 CNV neurons with highly aberrant karyotypes containing whole or substantial losses on multiple chromosomes. Moreover, we find that CNV location appears to be nonrandom. Recurrent regions of neuronal genome rearrangement contain fewer, but longer, genes.
Single cell genome sequencing approaches have identified somatic copy number variants (CNVs) in human neurons, but small sample sizes (<100 neurons) have limited the power to find recurrent patterns such as CNV hotspots in a single individual. Here, the authors develop an approach to map CNVs in 2097 neurons from a neurotypical individual, finding that >10% neurons contain at least one somatic CNV, and enabling deeper investigation of these events.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 University of Michigan Medical School, Department of Computational Medicine and Bioinformatics, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370)
2 Lieber Institute for Brain Development, Baltimore, USA (GRID:grid.429552.d) (ISNI:0000 0004 5913 1291)
3 University of Michigan Medical School, Department of Human Genetics, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370)
4 School of Medicine, Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, USA (GRID:grid.27755.32) (ISNI:0000 0000 9136 933X); Universidad San Sebastián, Sede de la Patagonia, Facultad de Medicina y Ciencia, Puerto Montt, Chile (GRID:grid.442215.4) (ISNI:0000 0001 2227 4297)
5 San Diego, Department of Neurosciences, University of California, La Jolla, USA (GRID:grid.266100.3) (ISNI:0000 0001 2107 4242)
6 Los Angeles, University of California, Los Angeles, USA (GRID:grid.468726.9) (ISNI:0000 0004 0486 2046)
7 Boston Children’s Hospital, Boston, USA (GRID:grid.2515.3) (ISNI:0000 0004 0378 8438)
8 Harvard University, Boston, USA (GRID:grid.38142.3c) (ISNI:0000 0004 1936 754X)
9 Icahn School of Medicine at Mount Sinai, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351)
10 Kennedy Krieger Institute, Baltimore, USA (GRID:grid.240023.7) (ISNI:0000 0004 0427 667X)
11 Mayo Clinic, Department of Quantitative Health Sciences, Rochester, USA (GRID:grid.66875.3a) (ISNI:0000 0004 0459 167X)
12 Sage Bionetworks, Seattle, USA (GRID:grid.430406.5) (ISNI:0000 0004 6023 5303)
13 Salk Institute for Biological Studies, La Jolla, USA (GRID:grid.250671.7) (ISNI:0000 0001 0662 7144)
14 Stanford University, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956)
15 Universitat Pompeu Fabra, Barcelona, Spain (GRID:grid.5612.0) (ISNI:0000 0001 2172 2676)
16 University of Barcelona, Barcelona, Spain (GRID:grid.5841.8) (ISNI:0000 0004 1937 0247)
17 University of Virginia, Charlottesville, USA (GRID:grid.27755.32) (ISNI:0000 0000 9136 933X)
18 Yale University, New Haven, USA (GRID:grid.47100.32) (ISNI:0000 0004 1936 8710)
19 Lieber Institute for Brain Development, Baltimore, USA (GRID:grid.429552.d) (ISNI:0000 0004 5913 1291); Johns Hopkins School of Medicine, Department of Psychiatry and Behavioral Sciences and Neuroscience, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311); Johns Hopkins School of Medicine, McKusick-Nathans Institute of Genetic Medicine, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311)
20 University of Michigan Medical School, Department of Computational Medicine and Bioinformatics, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370); University of Michigan Medical School, Department of Human Genetics, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370)